254 related articles for article (PubMed ID: 36183389)
41. Significant associations between bone mineral density and vascular calcification in patients with different stages of chronic kidney disease.
Uhlinova J; Kuudeberg A; Metsküla K; Lember M; Rosenberg M
BMC Nephrol; 2022 Oct; 23(1):327. PubMed ID: 36199013
[TBL] [Abstract][Full Text] [Related]
42. Smooth Muscle-Selective Nuclear Factor-κB Inhibition Reduces Phosphate-Induced Arterial Medial Calcification in Mice With Chronic Kidney Disease.
Yoshida T; Yamashita M; Horimai C; Hayashi M
J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29146611
[TBL] [Abstract][Full Text] [Related]
43. The interplay between mineral metabolism, vascular calcification and inflammation in Chronic Kidney Disease (CKD): challenging old concepts with new facts.
Viegas C; Araújo N; Marreiros C; Simes D
Aging (Albany NY); 2019 Jun; 11(12):4274-4299. PubMed ID: 31241466
[TBL] [Abstract][Full Text] [Related]
44. Connections between vascular calcification and progression of chronic kidney disease: therapeutic alternatives.
Hruska KA; Mathew S; Davies MR; Lund RJ
Kidney Int Suppl; 2005 Dec; (99):S142-51. PubMed ID: 16336568
[TBL] [Abstract][Full Text] [Related]
45. Role of Vitamin K in Chronic Kidney Disease: A Focus on Bone and Cardiovascular Health.
Bellone F; Cinquegrani M; Nicotera R; Carullo N; Casarella A; Presta P; Andreucci M; Squadrito G; Mandraffino G; Prunestì M; Vocca C; De Sarro G; Bolignano D; Coppolino G
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563672
[TBL] [Abstract][Full Text] [Related]
46. Osteoporosis in Patients with Chronic Kidney Diseases: A Systemic Review.
Hsu CY; Chen LR; Chen KH
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961953
[TBL] [Abstract][Full Text] [Related]
47. The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease.
Williams MJ; Sugatani T; Agapova OA; Fang Y; Gaut JP; Faugere MC; Malluche HH; Hruska KA
Kidney Int; 2018 Jan; 93(1):147-158. PubMed ID: 28843411
[TBL] [Abstract][Full Text] [Related]
48. The role of phosphate-containing medications and low dietary phosphorus-protein ratio in reducing intestinal phosphorus load in patients with chronic kidney disease.
Li J; Wang L; Han M; Xiong Y; Liao R; Li Y; Sun S; Maharjan A; Su B
Nutr Diabetes; 2019 Apr; 9(1):14. PubMed ID: 30944300
[TBL] [Abstract][Full Text] [Related]
49. Future treatment of vascular calcification in chronic kidney disease.
Cozzolino M; Maffei Faccioli F; Cara A; Boni Brivio G; Rivela F; Ciceri P; Magagnoli L; Galassi A; Barbuto S; Speciale S; Minicucci C; Cianciolo G
Expert Opin Pharmacother; 2023; 24(18):2041-2057. PubMed ID: 37776230
[TBL] [Abstract][Full Text] [Related]
50. Magnesium as a Calcification Inhibitor.
Hénaut L; Massy ZA
Adv Chronic Kidney Dis; 2018 May; 25(3):281-290. PubMed ID: 29793668
[TBL] [Abstract][Full Text] [Related]
51. Chronic Kidney Disease with Mineral Bone Disorder and Vascular Calcification: An Overview.
Izzo C; Secondulfo C; Bilancio G; Visco V; Virtuoso N; Migliarino S; Ciccarelli M; Di Pietro P; La Mura L; Damato A; Carrizzo A; Vecchione C
Life (Basel); 2024 Mar; 14(3):. PubMed ID: 38541742
[TBL] [Abstract][Full Text] [Related]
52. Dietary Phosphorus as a Marker of Mineral Metabolism and Progression of Diabetic Kidney Disease.
Winiarska A; Filipska I; Knysak M; Stompór T
Nutrients; 2021 Feb; 13(3):. PubMed ID: 33673618
[TBL] [Abstract][Full Text] [Related]
53. NRF2-suppressed vascular calcification by regulating the antioxidant pathway in chronic kidney disease.
Jin D; Lin L; Xie Y; Jia M; Qiu H; Xun K
FASEB J; 2022 Jan; 36(1):e22098. PubMed ID: 34918390
[TBL] [Abstract][Full Text] [Related]
54. Calcium as a cardiovascular toxin in CKD-MBD.
Moe SM
Bone; 2017 Jul; 100():94-99. PubMed ID: 27576942
[TBL] [Abstract][Full Text] [Related]
55. The bone-vessel axis in chronic kidney disease: An update on biochemical players and its future role in laboratory medicine.
Pereira L; Frazão JM
Clin Chim Acta; 2020 Sep; 508():221-227. PubMed ID: 32422129
[TBL] [Abstract][Full Text] [Related]
56. MICS, an easily ignored contributor to arterial calcification in CKD patients.
Zhang K; Gao J; Chen J; Liu X; Cai Q; Liu P; Huang H
Am J Physiol Renal Physiol; 2016 Oct; 311(4):F663-F670. PubMed ID: 27335374
[TBL] [Abstract][Full Text] [Related]
57. Vascular calcification in chronic kidney disease: a review.
de Oliveira RB; Okazaki H; Stinghen AE; Drüeke TB; Massy ZA; Jorgetti V
J Bras Nefrol; 2013; 35(2):147-61. PubMed ID: 23812573
[TBL] [Abstract][Full Text] [Related]
58. High-serum phosphate and parathyroid hormone distinctly regulate bone loss and vascular calcification in experimental chronic kidney disease.
Carrillo-López N; Panizo S; Alonso-Montes C; Martínez-Arias L; Avello N; Sosa P; Dusso AS; Cannata-Andía JB; Naves-Díaz M
Nephrol Dial Transplant; 2019 Jun; 34(6):934-941. PubMed ID: 30189026
[TBL] [Abstract][Full Text] [Related]
59. Restoration of microRNA-30b expression alleviates vascular calcification through the mTOR signaling pathway and autophagy.
Xu TH; Qiu XB; Sheng ZT; Han YR; Wang J; Tian BY; Yao L
J Cell Physiol; 2019 Aug; 234(8):14306-14318. PubMed ID: 30701530
[TBL] [Abstract][Full Text] [Related]
60. Vascular calcification is associated with Wnt-signaling pathway and blood pressure variability in chronic kidney disease rats.
Liao R; Wang L; Li J; Sun S; Xiong Y; Li Y; Han M; Jiang H; Anil M; Su B
Nephrology (Carlton); 2020 Mar; 25(3):264-272. PubMed ID: 31709686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
